Skip to content
OpenCapital
Get started

Arvinas ARVN Other Research And Development Expense

Other Research And Development Expense at other companies

Celanese Corporation logo
Celanese CorporationCE
$0—
Comstock Inc. logo
Comstock Inc.LODE
$0-100%
Disc Medicine logo
Disc MedicineIRON
$2.17M+18.2%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$0—
TG Therapeutics logo
TG TherapeuticsTGTX
$43.52M+1.1%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$1.49M+25.5%

Segments

By segment

See full
Reportable Segment$2.4M-22.6%

Other financials

Income statement

See full
Revenue$15.6M-91.7%
Operating income-$63.8M-189%
Net income-$57.6M-169%
EPS (diluted)-$0.90-179%

Balance sheet

See full
Cash & equivalents$87.3M+7.8%
Total debt$8.6M-19.6%
Total equity$386.8M-41.4%
Total assets$647.5M-35.3%

Cash flow

See full
Operating cash flow-$69.2M+22.2%
CapEx$1.3M+225%
Free cash flow-$70.5M+21.1%

Valuation

See full
Market cap$518.11M-4.6%
Enterprise value$439.41M-7.1%
P/S5.8×+4.5×

Profitability

See full
Operating margin-283.8%-310pp
Net margin-247.5%-260pp
FCF margin-287.4%—

Returns & leverage

See full
Return on equity-42.3%-53.5pp
Debt / equity0×0.0×
Current ratio5.4×+0.9×